跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Barozin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Barozin
Approved
STANDARD
Barozin
Nanz Med Science Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ccc7df412fe9d146
Company
Nanz Med Science Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ccc7df412fe9d146
Drug Approval Philippines Name
Barozin
Product Name
Barozin
Registration Number
DRP-13043
Brand Name
Barozin
Generic Name
Mupirocin
Dosage Form
Ointment
Dosage Strength
20 mg/g (2% w/w)
Manufacturer
Nanz Med Science Pharma Pvt. Ltd.
Importer
Pharma-Surrey International, Inc.
Distributor
Pharma-Surrey International, Inc.
Issuance Date
24 November 2022
Expiry Date
24 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ccc7df412fe9d146
Type
Standard
Back to Philippines FDA Approvals